Once-Monthly Injectable Olanzapine Wins Over Patients and Clinicians in Landmark Survey
A new survey of patients and healthcare professionals from the phase 3 SOLARIS trial finds strong satisfaction with a once-monthly ...
A new survey of patients and healthcare professionals from the phase 3 SOLARIS trial finds strong satisfaction with a once-monthly ...
Schizophrenia care may be entering a more integrated phase as researchers examine what happens when long-acting injectable antipsychotics are combined ...
In recent years, the treatment landscape for schizophrenia has witnessed significant advancements, especially concerning the development of long-acting injectable antipsychotics. ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine